Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Theodore Alan Huizenga

Svp, Chief Accounting Officer at Ultragenyx Pharmaceutical Inc. (RARE)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $60K

Reported trades

Filed Stock Type Shares Price Value Since
Sep 15SEC RAREUltragenyx Pharmaceutical Inc. Sell Plan 1,28367,863 held (−2%) $13.57 $17K +7.1%
Sep 8SEC RAREUltragenyx Pharmaceutical Inc. Sell 16169,146 held (−0%) $13.99 $2K +3.9%
Mar 3SEC RAREUltragenyx Pharmaceutical Inc. Sell 1,63248,670 held (−3%) $22.80 $37K -36.2%
Dec 30SEC RAREUltragenyx Pharmaceutical Inc. Sell 8550,450 held (−0%) $34.38 $3K -57.7%
  • Sell

    Svp, Chief Accounting Officer Theodore Alan Huizenga sold $17K of RARE at $13.57 — pre-scheduled 10b5-1 plan sale.